With our continuum from research to the clinic we support throughout your projects from R&D to GMP grade. We provide purified and highly concentrated particles from small scale to large scale with the same vector specifications.
Using both technologies, Flash Therapeutics can recover a wide range of therapeutics fields
We look forward to negotiate partnerships and licensing agreements with pharmaceutical or biotechnological companies for the utilization, further development and global commercialization of the proprietary LentiFlash® delivery system.Join us
Discover our own internal product candidates and collaborative programmes
Fibrosis is a condition lacking therapeutic interventions. The study by Christian Stockmann provides proof of principle for vaccination as an immunotherapeutic approach to treat organ fibrosis (par...